Bipolar Disorders Clinical Trial
— CONCORDEBipolar disorders are common psychiatric disorders characterized by severe and recurrent symptomatic periods (Major Depressive Episode, mania, hypomania) and interictal periods characterized by persistent residual symptoms, impaired functioning and quality of life. In addition, the prognosis of bipolar disorder is aggravated by an increased risk of suicide and a high frequency of somatic comorbidities. Poor adherence is one of the major factors influencing the course of the disorder and one of the causes of ineffective treatments. Considering that between 20 and 60% of patients with bipolar disorder have problems with adherence. Adherence is modulated by a number of socio-demographic, clinical and neuropsychological factors. It is also modulated by the knowledge, beliefs and In addition, studies have shown that the reasons attributed to poor adherence are different depending on whether questioning patients or healthcare professionals. This fault diagnosis, assessment of the causes and "fit" into the reasons associated with poor adherence is an aggravating factor of the problem. However, this factor seems modifiable by better training of professionals. A team from Newcastle University in England has developed a training program for all health professionals to improve the diagnosis and understanding of compliance issues in bipolar patients and provide simple tools to fight against patients with this problem. The investigators assume that this training will improve medication adherence among outpatients by trained professionals.
Status | Not yet recruiting |
Enrollment | 300 |
Est. completion date | June 2020 |
Est. primary completion date | June 2019 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Suffering from bipolar disorder type 1, type 2 or unspecified according to the DSM IV - Do not presenting mood episode as defined in DSM IV - With at least one medication prescribed mood stabilizer goal, whatever its observance Exclusion Criteria: - Patients full-time hospitalized at the time of inclusion |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
France | Assistance Publique Hôpitaux de Marseille | Marseille |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique Hopitaux De Marseille |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference of score of Medication Adherence Rating Scale (MARS) before and after the training of the professionals | 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05537376 -
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
|
N/A | |
Completed |
NCT00240721 -
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
|
Phase 3 | |
Completed |
NCT02242669 -
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
|
N/A | |
Completed |
NCT01821469 -
Functional Correlates of Bipolar Disorders and Effects of the Psychoeducation. an fMRI Study
|
N/A | |
Completed |
NCT00888264 -
A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder
|
N/A | |
Completed |
NCT02807688 -
Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses
|
N/A | |
Completed |
NCT00253162 -
A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
|
Phase 3 | |
Completed |
NCT01729650 -
Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)
|
N/A | |
Recruiting |
NCT02843906 -
Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?
|
N/A | |
Completed |
NCT01377896 -
The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours
|
N/A | |
Completed |
NCT00453804 -
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
|
Phase 4 | |
Terminated |
NCT00047567 -
Open-label Adjunctive Zonisamide for Bipolar Disorder
|
Phase 4 | |
Completed |
NCT03028545 -
Representations and Strategies for Recovery
|
N/A | |
Completed |
NCT00156325 -
Escitalopram as a Mood Stabilizer for Bipolar II Disorder
|
Phase 2 | |
Completed |
NCT06034769 -
Oral and Jaw Health in Bipolar Patients
|
||
Terminated |
NCT02936466 -
Evaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group
|
N/A | |
Completed |
NCT00845988 -
Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
|
Phase 4 | |
Completed |
NCT00257075 -
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
|
Phase 3 | |
Recruiting |
NCT01188395 -
Bipolar Disorder With Alcoholism in Han Chinese
|
N/A | |
Completed |
NCT01188148 -
Series Studies of Bipolar Disorder-Valproate add-on Memantine
|
Phase 2/Phase 3 |